Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial

ConclusionsReductions in pain and fatigue were associated with improved daily activity and work productivity for all RA patients and for baricitinib-treated patients in RA-BEAM.Trial RegistrationClinicalTrials.gov identifier, NCT01710358.FundingIncyte Corporation and Eli Lilly and Company.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research